We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > VERAXA

News List

Veraxa Biotech and Indivumed to Jointly Develop Precision Oncology Antibody Drugs contractpharma
August 11, 2021
Veraxa Biotech GmbH and Indivumed GmbH have entered an agreement to jointly discover modulatory and functional antibodies against several targets that are relevant for colorectal cancer.
VERAXA Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody Drugs b3cnewswire
August 11, 2021
VERAXA Biotech GmbH, Heidelberg, and Indivumed GmbH, Hamburg, announced today their agreement to jointly discover modulatory and functional antibodies against several targets that are relevant for colorectal cancer.
VERAXA and Quadira Enter ADC Development Partnership contractpharma
June 16, 2021
VERAXA Biotech GmbH (former Velabs Therapeutics GmbH), an ADC engineering and functional antibody screening company, has entered into a partnership with Quadira Biosciences AG of Zug, Switzerland, to develop a suite of novel ADCs for the treatment of ...
VERAXA Biotech and Quadira Biosciences Enter Partnership on ADC Development b3cnewswire
June 15, 2021
VERAXA Biotech GmbH (former Velabs Therapeutics GmbH), announced today that it has entered into a partnership agreement with Quadira Biosciences AG, Zug, Switzerland， to jointly develop a suite of novel ADCs for the treatment of oncological conditions.